163 results on '"Bratman S"'
Search Results
2. The Prognostic and Predictive Value of Pre-Treatment Total Lymphocyte Count in HPV+ Oropharyngeal Carcinoma Receiving Definitive (Chemo-) Radiation
3. Simulating Cell-Free Chromatin Using Breast and Colorectal Cancer Preclinical Models for Cancer-Specific Biomarker Discovery
4. Heterochromatin Profiling in Lymphoma Patient Plasma for the Discovery of Novel Chromatin Variants
5. 9P Early circulating tumor DNA (ctDNA) kinetics and gene expression analysis to predict treatment outcomes with anti-PD-1 therapy
6. Outcomes after definitive (C)RT in HPV plus OPC: Largescale comparison of two population-based cohorts
7. Clinical Behavior and Outcome of HPV-Positive Nasopharyngeal Carcinoma
8. SP-0226 Biomarker-guided precision radiotherapy
9. OC-0518 Impact of observer knowledge on AI delineation assessments: Bias in clinical acceptability testing
10. Non-invasive prediction of lymph node risk in oral cavity cancer patients
11. 866P Prognostic performance of a genome-wide methylome enrichment platform in head and neck cancer
12. 1910P Evaluation of a genome-wide methylome enrichment platform for circulating tumor DNA quantification and prognostic performance in renal cell carcinoma (RCC)
13. 2201P Malignant pleural mesothelioma (MPM)-specific DNA methylation patterns in patients using liquid biopsies
14. 77TiP From liquid biopsy to cure: Using CtDNA detection of minimal residual disease to identify patients for curative therapy after non-small cell lung cancer (NSCLC) resection
15. P14.24 Evolution of TCR Clonality during Chemoradiation and Durvalumab as Predictors of Survival in Stage 3 NSCLC
16. PO-1549: Non-invasive prediction of lymph node risk in oral cavity cancer patients
17. PO-0805: Dental insurance status influences prophylactic dental care prior to head and neck radiation
18. PO-1583: Non-invasive radiomic imaging prediction of tumour hypoxia: biomarker for FLASH irradiation?
19. 977TiP Role of microbiome as a biomarker in locoregionally-advanced oropharyngeal squamous cell carcinoma 2 (ROMA LA-OPSCC2)
20. 947P Association between genetic variants and cisplatin nephrotoxicity: A genome-wide approach
21. Non-invasive prediction of lymph node risk in oral cavity cancer patients using a combination of supervised and unsupervised machine learning algorithms
22. P1.14-07 Genomic Profiling of Liquid Biopsies During 2nd/3rd Generation ALK Inhibitor Therapy to Identify Novel Mechanisms of Resistance
23. P2.14-62 Early, Subclinical SCLC Transformation in Patients with EGFR Mutant Lung Cancer Receiving Osimertinib, Detected Through Cell-Free DNA
24. Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single agent pembrolizumab (P)
25. Treatment Outcomes and Survival Following Primary (chemo) Radiotherapy in HPV+ Oropharynx Cancer: A Largescale Comparison of Two Institutions
26. PS1027 ASSESSMENT OF MOLECULAR MRD KINETICS BY ERROR-CORRECTED NEXT-GENERATION SEQUENCING PROVIDES INDEPENDENT PROGNOSTIC INFORMATION IN ADULT AML PATIENTS
27. EP-1201 Outcomes in young patients (<40) treated for oral cavity squamous cell carcinoma in the modern era
28. SP-0227 Cancer detection using methylated cell-free DNA
29. PO-0733 Non-invasive imaging for tumor hypoxia: a novel validated CT and FDG-PET-based Radiomic signature.
30. OC-007 Radiologic extranodal extension portends worse outcome in TNM-8 cT1-T2N1 HPV + oropharyngeal cancer
31. Abstract OT1-12-01: Exploration of factors associated with imminent risk of late recurrence in hormone receptor positive breast cancer
32. Radiologic-Pathologic Correlation of Tumor Thickness and Its Prognostic Importance in Squamous Cell Carcinoma of the Oral Cavity: Implications for the Eighth Edition Tumor, Node, Metastasis Classification
33. Clinical Profile and Outcome of Viral-Mediated Pharyngeal Carcinoma at a Western Institution
34. SP-0113: Circulating tumour DNA as a therapeutic biomarker for radiotherapy
35. OC-0277: Development and validation of distant metastases risk group classification in oral cavity cancer
36. PO-0710: Brain dose from IMRT is associated with neurocognitive function in nasopharyngeal cancer survivors
37. PO-0709: Postoperative salvage therapy for early recurrence in oral cavity squamous cell carcinoma
38. Outcomes of Oral Cavity Cancer Patients Treated with Definitive Radiation Therapy
39. Potential Impact of the 8th edition UICC/AJCC Staging in Oral Cavity Cancer Patients Treated With Surgery and Post-Operative Intensity Modulated Radiation Therapy
40. Automated Assessment of Nasopharynx Cancer GTV Change on Daily Cone Beam CT
41. PV-0506: Comparison of Clinical Behavior of Viral Related Oropharyngeal and Nasopharyngeal Carcinoma
42. PO-0606: Mandible osteoradionecrosis in oropharynx carcinoma treated with IMRT: Smoking and tumor size matter
43. PO-0620: Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiotherapy Regimen
44. OC-022: Association of patient derived xenograft formation with oral cavity squamous cell cancer outcomes
45. 113P - Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single agent pembrolizumab (P)
46. EP-1093: Impact of comorbidity, polypharmacy and HPV status in elderly patient with oropharyngeal cancer
47. PO-0631: The prognostication of tumour volume and lower neck lymph nodes in laryngeal cancer treated with IMRT
48. Reaffirming Metastatic Risk Profiles in Human Papillomavirus-related Oropharyngeal Cancer Following Definitive Radiation Therapy With or Without Chemotherapy
49. Natural Course Following Failure After Definitive Chemoradiation Therapy in HPV-Related and HPV-Unrelated Oropharyngeal Cancer
50. Risk Stratification for Relapse in Human Papillomavirus–Unrelated Oropharyngeal Carcinoma Treated With Definitive Radiation Therapy With or Without Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.